Vaxart, Inc. (NASDAQ:VXRT) Q4 2025 Earnings Call Transcript March 12, 2026 Vaxart, Inc. beats earnings expectations. Reported EPS is $0.239, expectations were $-0.08. Operator: Greetings, and welcome ...
According to a team of researchers at Baylor College of Medicine, Tongji University and collaborating institutions, weaning ...
Mayo Clinic researchers have developed a promising new way to deliver treatment directly to cholangiocarcinoma tumors, a rare and aggressive bile duct cancer with limited treatment options, using milk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results